Articles tagged with Chronic Obstructive Pulmonary Disease
A recent study found that warmer temperatures are associated with an increase in COPD exacerbations. The research analyzed data from over 1,100 smokers with COPD and discovered a 2% increased risk of exacerbations for every one-degree Celsius rise in ambient temperature.
The study found that patients with low risk of exacerbations do not benefit from low to moderate dose inhaled corticosteroids, while high doses are associated with severe side effects. Tailoring treatment according to patient characteristics, such as age and blood cell count, can minimize over- and underuse of inhaled corticosteroids.
A new clinical study reveals that treatment with mesenchymal stromal cells reduces inflammation in patients with chronic obstructive pulmonary disease (COPD). The study provides insights into the therapeutic potential of MSCs as a novel treatment for COPD, which is a leading cause of morbidity and mortality worldwide.
Researchers found individuals with well-controlled asthma have significantly lower odds of hospitalization and ICU admission compared to those with uncontrolled asthma. Asthma patients using their medications showed a decrease in worsened COVID-19 outcomes.
Computational modeling reveals that smaller drug particles can reach the distal region of airways, improving treatment efficacy. The study aims to enhance inhaler design and reduce drug loss, benefiting patients with respiratory illnesses.
Researchers have modelled how drugs are delivered to the respiratory tract via an inhaler to better treat lung diseases. Finer drug particles of around one micron are better able to travel further into the lungs.
The European Respiratory Society has announced the press registration and program for its upcoming International Congress 2021. Over 4,000 presentations on various lung health topics will be presented during the event.
Researchers at Weill Cornell Medicine have discovered that injecting mice with pulmonary endothelial cells can reverse the symptoms of emphysema. The study found that targeting endothelial cell function may represent a strategy for treating patients with advanced COPD or emphysema. Injecting healthy lung endothelial cells and/or inhibi...
A team of researchers identified a protein called FCHSD1 involved in COPD-related inflammation and cell death. Mice lacking FCHSD1 showed reduced inflammation and apoptosis, suggesting its inhibition as a potential therapy for emphysema.
The study found that AIM2 inflammasome is at the intersection of COPD and lung cancer, with higher expression correlating to lower survival rates in smoking COPD adenocarcinoma patients. This suggests that the AIM2 inflammasome may be a potential target for developing novel treatments for COPD patients who develop lung cancer.
Dr. Jessica Blackburn of Vanderbilt University has been awarded a $100,000 ATS/GSK Research Grant to investigate COPD epithelial remodeling and the role of YAP/TAZ activation in the disease. The grant will support her studies on COPD's cellular mechanisms.
Research finds that exposure to metals in PM2.5 exacerbates cardiovascular autonomic dysfunction in COPD patients, leading to increased heart rates. The study provides valuable insights into the disease burden of COPD associated with air pollution in China.
Researchers from UNC School of Medicine discovered that MUC5AC is more reliably associated with COPD manifestation than another mucus protein, revealing a possible biomarker for disease initiation and prognosis. Elevated levels of MUC5AC in non-smokers who developed COPD suggest it could predict disease progression.
Researchers at Hokkaido University have identified a unique defense mechanism against SARS-CoV-2, involving the viral pattern recognition receptor RIG-I. Upregulating RIG-I expression may help predict COVID-19 patient outcomes and could be a potential strategy to control SARS-CoV-2 infection.
A new algorithm will be developed to predict hospital readmissions for patients with COPD, using a combination of social information and clinical data. The goal is to provide personalized care management interventions and reduce early hospital readmissions.
A study found that two-fifths of Medicare beneficiaries with chronic obstructive pulmonary disease (COPD) have limited access to pulmonary rehabilitation services. The researchers identified significant disparities in access across urban, suburban, and rural areas.
Researchers at Boston University School of Medicine have identified a panel of genes that are active in smokers and ex-smokers who experience faster loss of lung function. These genes may be useful to predict which people are most at risk for smoking-related decline in lung function, offering hope for early diagnosis and treatment.
Researchers found that high levels of particulate matter exposure were associated with a 60% higher chance of hospitalization in COVID-19 patients with pre-existing respiratory disease. Patients without respiratory disease showed no increased risk. Air pollution may have policy implications, such as reducing particulate exposure.
Researchers identified a genetic pathway that could help treat chronic obstructive pulmonary disease (COPD) by sweeping out excess mucus from the lungs. The pathway involves the ANT2 gene, which produces proteins that enhance cilia function and hydration layer formation in lung cells.
A study published in Radiology found that chest CT scans can assess body composition and predict mortality risk in people with chronic obstructive pulmonary disease (COPD). Higher intermuscular fat was linked to higher mortality rates, while subcutaneous adipose tissue was associated with lower risks.
Researchers are investigating how sleep affects lung health and exercise tolerance in African Americans compared to Caucasian smokers, thanks to a $30,000 grant from the CHEST Foundation. The study aims to identify potential associations between sleep deficiency, smoking, and lung health disparities in high-risk African American adults.
A new study implicates a type of immune cell in the development of chronic lung disease following viral infection. Measuring dendritic cells may help doctors identify high-risk patients.
A team of engineers at the University of Cambridge identified the physical mechanisms responsible for wheezing, a condition affecting up to a quarter of the world's population. They developed a 'tube law' to predict when wheezing occurs and could lead to a cheaper and faster diagnostic for lung disease.
A new algorithm developed by researchers at the University of Copenhagen can detect unusual disease trajectories in COPD patients that may indicate a different diagnosis, such as lung cancer. The algorithm was trained on data from 284,000 patients and identified approximately 69,000 typical disease trajectories.
Researchers found that inhaling unfragmented hyaluronan improves lung function in patients with severe COPD, shortening hospital stays and decreasing breathing support needs. The treatment also aids mucus transport and promotes recovery.
Researchers found that Ninjin'yoeito enhanced PGC-1α expression in skeletal muscle, improving muscle mass loss in aging mice. This study suggests a potential treatment for COPD patients with severe sarcopenia frailty.
Researchers found that nearly all insulation materials, except aerogels, were associated with chest infections. Insulators are also at risk of developing chronic obstructive pulmonary disease (COPD) from exposure to asbestos.
Researchers found significant differences in gut microbiome and metabolite profiles between COPD patients and healthy individuals. The study suggests that stool sampling could be used to non-invasively diagnose and monitor for COPD.
The new ATS clinical practice guideline provides comprehensive guidance on long-term and ambulatory oxygen therapy for adults with COPD and ILD. The guideline recommends LTOT for severe chronic resting room air hypoxemia in both COPD and ILD patients, and suggests ambulatory oxygen for moderate exertional room air hypoxemia in COPD pat...
A study published in Information Systems Research found that online reviews of physicians do not reliably indicate the quality of care provided by a physician, especially for chronic-disease patients. The researchers examined 10 years of COPD patient admission-discharge data and scored online reviews on one of the ranking websites.
Researchers at Helmholtz Munich have found a promising therapeutic approach against COPD by blocking lung epithelial cell death and triggering tissue regeneration. The novel treatment targets the lymphotoxin beta receptor signaling pathway, leading to improved lung function and reduced comorbidities.
Temple Lung Center enrolls first patient in RejuvenAir clinical trial to treat moderate to severe COPD with CB; aims to address daily symptom burden and hospitalization risk. The system delivers metered doses of liquid nitrogen spray to targeted airways, potentially allowing new cells to regrow.
A study published in the Annals of the American Thoracic Society found that wearing face masks has minimal impact on gas exchange in healthy individuals and those with severe lung impairment. The researchers stress the importance of wearing masks to prevent COVID-19 infection, especially for patients with lung disease.
A collection of articles reviews the literature on using isokinetic testing to measure muscle strength in older adults with conditions such as COPD and stroke. The studies provide evidence for the validity and reliability of isokinetic strength testing, but highlight limitations in responsiveness and practicality.
Researchers found a significant association between cannabinoids and negative respiratory health effects in older adults with COPD. The study, published in Thorax, showed that higher doses of cannabinoids were linked to increased hospitalizations and all-cause death among patients with the disease.
A Rutgers-led national survey found that 83% of doctors strongly believed nicotine contributed to heart disease, despite its primary risk being addiction. The study suggests physicians need better understanding of nicotine risks to assist patients addicted to tobacco products.
The American Thoracic Society has released new practice guidelines on non-invasive ventilation in chronic stable Hypercapnic COPD. The guidelines recommend using nocturnal NIV in addition to usual care and screening patients for obstructive sleep apnea before initiating long-term therapy.
Researchers discovered neuromedin B, a nervous system protein, prevents overactive immune responses and damaging inflammation in diseases like asthma, allergies, and COPD. The study provides hope for possible treatments using NMB to treat inflammatory diseases.
Researchers identified lung-related factors associated with increased hip fracture risk in smokers, including emphysema and COPD exacerbations. These findings suggest that osteoporosis screening and management decisions should consider lung health in at-risk patients.
Researchers at University of Huddersfield found that the benefits of using inhalers and nebulisers containing steroids outweigh the risks despite COVID-19 concerns. The study confirms that patients with asthma or COPD can continue using their regular medicines, including steroids.
Researchers discovered a link between small airways and increased COPD risk in non-smokers. People with smaller airways relative to their lungs may have lower breathing capacity, making them more susceptible to COPD.
A new study found that people with small airways relative to their lungs' volume are at increased risk of chronic obstructive pulmonary disease (COPD) regardless of smoking habits. Individuals with smaller airways had the poorest lung function and were 8 times more likely to develop COPD.
A compact sensor system using modified carbon nanotubes detects high concentrations of nitrogen dioxide in exhaled air, indicating chronic obstructive pulmonary disease (COPD) or other respiratory issues. The device's sensitivity is shown to detect biomarkers for specific diseases, including lung cancer and asthma.
A study of nearly 200,000 Medicare patients found that starting pulmonary rehabilitation within 90 days of COPD hospitalization significantly improves one-year survival. Pulmonary rehabilitation combines exercise training and self-management education.
A new study has found that people with chronic obstructive pulmonary disease (COPD) and smokers are at a higher risk of severe complications and mortality from COVID-19. Researchers analyzed data from over 2,500 patients with COVID-19 and found that COPD was associated with a 63% risk of severe disease and a 60% risk of mortality.
A study published in the Journal of American Biomedical Science & Research found that higher doses of statins and long-acting inhalers for chronic obstructive pulmonary disease may not provide significant benefits for most patients, given the costs and risks involved.
The study suggests that women have a lower threshold for seeking primary healthcare compared to men, with older women living longer with disabling conditions. This difference may be due to various factors such as fear of diagnosis or differences in symptom recognition.
Abnormal stem cells in COPD patients drive key features of the disease, including mucins that block airways and fibrosis and inflammation. Researchers have identified specific cells responsible for COPD pathology and are screening them against drug libraries to discover new treatments.
The American Thoracic Society recommends LABA/LAMA combination therapy for COPD patients experiencing dyspnea or exercise intolerance. This guideline also suggests considering triple therapy and withdrawing inhaled corticosteroids if no exacerbations occur.
A study published in the European Respiratory Journal found that people with COPD and smokers have higher levels of ACE-2, a molecule that allows coronavirus to infect lung cells. Former smokers had similar levels of ACE-2 as non-smokers, highlighting the importance of quitting smoking to protect against COVID-19.
Research published in Thorax journal found a heightened risk of lung cancer in people with COPD who have never smoked. The risk is comparable to that of smokers without chronic lung disease, suggesting early detection may reduce treatment complications.
A new study published in the American Journal of Respiratory and Critical Care Medicine reports that a three-drug combination of fluticasone furoate, umeclidinium, and vilanterol reduces all-cause mortality by 42% in patients with chronic obstructive pulmonary disease (COPD) treated with an inhaler once daily.
A UK study emphasizes the significance of spirometry in identifying chronic obstructive pulmonary disease (COPD), particularly among patients with respiratory symptoms. The study found that over-reliance on radiological changes alone may lead to incorrect diagnoses, highlighting the need for comprehensive assessments.
A recent study published in Arthritis & Rheumatology found that asthma and chronic obstructive pulmonary disease (COPD) are associated with a higher risk of developing rheumatoid arthritis. Women with asthma were 53% more likely to develop rheumatoid arthritis, while those with COPD were 89% more likely.
Researchers found that daily meetings among healthcare providers can significantly shorten hospital stays for COPD patients. Integrated care conferences (ICCs) resulted in an average length of stay reduction of 3.18 days compared to hospitals without ICCs.
A new study published in the Annals of the American Thoracic Society has found that traditional biomass stoves significantly increase indoor levels of harmful PM2.5 and carbon monoxide, leading to lung inflammation and potentially chronic obstructive pulmonary disease (COPD) in developing nations.
People living with HIV in Ontario have a 34% higher incidence rate of COPD, diagnosed at 50 years old vs. 62 for HIV-negative individuals, according to a study led by St. Michael's Hospital researchers. The study also found that women with HIV have a 54% higher risk of COPD.
A randomized controlled trial shows that lay health coaching can significantly improve inhaler use among low-income COPD patients, with 40% of health-coached patients demonstrating effective use of their inhalers. The intervention also improved inhaler technique, contributing to long-term COPD outcomes.
In a new study, Mayo Clinic researchers discovered that in-home bilevel positive airway pressure (BiPAP) therapy can significantly improve COPD patient outcomes, including reduced mortality rates and fewer hospital admissions. The treatment helps alleviate shortness of breath and reduces the risk of intubation.
Researchers at the University of Sheffield have identified a class of cancer drugs that accelerate neutrophil cell death and promote healing in the lungs. This breakthrough could lead to the development of effective treatments for chronic obstructive pulmonary disease (COPD), which affects millions worldwide.